Close

UPDATE: Ladenburg Thalmann Assumes Salarius Pharmaceuticals (SLRX) at Buy

September 23, 2021 6:35 AM EDT Send to a Friend
(Updated - September 23, 2021 6:36 AM EDT)

Ladenburg Thalmann analyst Ahu Demir assumes coverage on Salarius Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login